glp-1/gip dual agonist weight loss Understand Tirzepatide and Its Effect on Current Therapy Let's talk real numbers. 📊

The researchers analysis found a significant association between GLP-1 use and reduced breast cancer risk

The observed decrease in BMI supports the significance of weight control in the treatment of IIH and the connection between obesity-related processes and elevated intracranial pressure

Cost-effectiveness of once daily GLP-1 receptor agonist lixisenatide compared to bolus insulin both in combination with basal insulin for the treatment of patients with type 2 diabetes in Norway

Several case series ( Liraglutide Liraglutide is the only GLP-1RA, which has been investigated for the treatment of NAFLD

Heart failure with preserved ejection fraction (HFpEF) accounts for approximately half of all heart failure cases, with patients bearing a high symptomatic burden and physical limitations that impact their daily lives